Post-market study on the impact of surgical approach on total hip replacement outcome
- Conditions
- OsteoarthritisSurgery - Surgical techniquesMusculoskeletal - Osteoarthritis
- Registration Number
- ACTRN12616000806460
- Lead Sponsor
- The International Musculoskeletal Research Institute Incorporated
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 624
Any osteo-arthritic patient that presents to an Investigator for a routine hip replacement surgery and is able to provide informed consent.
Any patient able to complete the required patient reported outcome measures.
Any patient able to undergo the required radiological examinations.
Participants with difficulty in comprehending study protocol through written or verbal English
Participants who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up.
Concurrent pregnancy.
Participants who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.
Participants who are currently involved in any injury litigation claims.
Participants with chronic gait affecting neurological conditions (e.g. stroke, Parkinson’s, Multiple sclerosis).
Participants with congenital hip defects.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure for this study is the influence of three different surgical techniques on participant health-related quality of life (HRQoL) as assessed by the EuroQol-5D-5L (EQ-5D).[Pre-operatively, 2 weeks, 6 weeks, 3 months, 12 months and 24 months post-operatively];Identification of hip-specific function using the Oxford Hip Score (OHS)[Pre-operatively, 2 weeks, 6 weeks, 3 months, 12 months and 24 months post-operatively]
- Secondary Outcome Measures
Name Time Method